Zhejiang Jiuzhou Pharmaceutical Co., Ltd (603456.SS)
CNY 13.63
(-1.16%)
CNY 13.63
(-1.16%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.95 Billion CNY | -3.07% |
| 2022 | 2.02 Billion CNY | 20.19% |
| 2021 | 1.68 Billion CNY | 43.76% |
| 2020 | 1.16 Billion CNY | 41.31% |
| 2019 | 827.88 Million CNY | 54.76% |
| 2018 | 534.96 Million CNY | -1.38% |
| 2017 | 542.42 Million CNY | 18.41% |
| 2016 | 458.09 Million CNY | -20.03% |
| 2015 | 572.84 Million CNY | 20.86% |
| 2014 | 473.96 Million CNY | 30.68% |
| 2013 | 362.69 Million CNY | 21.65% |
| 2012 | 298.14 Million CNY | 20.12% |
| 2011 | 248.19 Million CNY | 30.28% |
| 2010 | 190.51 Million CNY | 26.95% |
| 2009 | 150.06 Million CNY | -3.61% |
| 2008 | 155.68 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.8 Billion CNY | -7.94% |
| 2024 Q2 | 1.83 Billion CNY | 1.8% |
| 2024 Q3 | 1.96 Billion CNY | 7.0% |
| 2023 Q2 | 1.79 Billion CNY | 0.08% |
| 2023 FY | 1.95 Billion CNY | -3.07% |
| 2023 Q1 | 1.79 Billion CNY | -11.36% |
| 2023 Q3 | 1.81 Billion CNY | 1.39% |
| 2023 Q4 | 1.95 Billion CNY | 7.76% |
| 2022 FY | 2.02 Billion CNY | 20.19% |
| 2022 Q4 | 2.02 Billion CNY | 10.47% |
| 2022 Q3 | 1.82 Billion CNY | 8.02% |
| 2022 Q2 | 1.69 Billion CNY | -2.51% |
| 2022 Q1 | 1.73 Billion CNY | 3.31% |
| 2021 Q1 | 1.31 Billion CNY | 12.36% |
| 2021 Q4 | 1.68 Billion CNY | 17.99% |
| 2021 Q2 | 1.42 Billion CNY | 8.75% |
| 2021 Q3 | 1.42 Billion CNY | -0.29% |
| 2021 FY | 1.68 Billion CNY | 43.76% |
| 2020 Q2 | 1.02 Billion CNY | 12.3% |
| 2020 FY | 1.16 Billion CNY | 41.31% |
| 2020 Q3 | 1.05 Billion CNY | 2.6% |
| 2020 Q4 | 1.16 Billion CNY | 10.75% |
| 2020 Q1 | 916.85 Million CNY | 10.75% |
| 2019 FY | 827.88 Million CNY | 54.76% |
| 2019 Q2 | 621.99 Million CNY | 3.82% |
| 2019 Q3 | 633.76 Million CNY | 1.89% |
| 2019 Q1 | 599.09 Million CNY | 11.99% |
| 2019 Q4 | 827.88 Million CNY | 30.63% |
| 2018 Q1 | 510.01 Million CNY | -5.97% |
| 2018 FY | 534.96 Million CNY | -1.38% |
| 2018 Q4 | 534.96 Million CNY | -4.71% |
| 2018 Q3 | 561.42 Million CNY | 7.36% |
| 2018 Q2 | 522.93 Million CNY | 2.53% |
| 2017 Q3 | 536.61 Million CNY | 0.62% |
| 2017 Q4 | 542.42 Million CNY | 1.08% |
| 2017 FY | 542.42 Million CNY | 18.41% |
| 2017 Q1 | 489.73 Million CNY | 6.91% |
| 2017 Q2 | 533.29 Million CNY | 8.89% |
| 2016 Q1 | 600.57 Million CNY | 4.84% |
| 2016 Q4 | 458.09 Million CNY | -7.22% |
| 2016 Q3 | 493.75 Million CNY | -10.73% |
| 2016 Q2 | 553.08 Million CNY | -7.91% |
| 2016 FY | 458.09 Million CNY | -20.03% |
| 2015 Q4 | 572.84 Million CNY | 4.43% |
| 2015 Q3 | 548.54 Million CNY | 5.29% |
| 2015 Q2 | 520.98 Million CNY | 12.55% |
| 2015 Q1 | 462.88 Million CNY | -2.34% |
| 2015 FY | 572.84 Million CNY | 20.86% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q4 | 473.96 Million CNY | 16.52% |
| 2014 Q2 | 374.51 Million CNY | 0.0% |
| 2014 Q3 | 406.75 Million CNY | 8.61% |
| 2014 FY | 473.96 Million CNY | 30.68% |
| 2013 Q4 | 362.69 Million CNY | 0.0% |
| 2013 FY | 362.69 Million CNY | 21.65% |
| 2012 FY | 298.14 Million CNY | 20.12% |
| 2011 FY | 248.19 Million CNY | 30.28% |
| 2010 FY | 190.51 Million CNY | 26.95% |
| 2009 FY | 150.06 Million CNY | -3.61% |
| 2008 FY | 155.68 Million CNY | 0.0% |